These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 918526)

  • 21. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of T lymphocyte depletion on susceptibility to influenza virus infection and development of anti-viral immunity in lethally irradiated mice reconstituted with syngeneic bone marrow grafts.
    Mumcuoglu M; Zakay-Rones Z; Parag G; Weiss L; Slavin S
    Bone Marrow Transplant; 1987 Dec; 2(4):403-12. PubMed ID: 3332187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
    Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
    J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural influenza A virus infection of mice elicits strong antibody response to HA2 glycopolypeptide.
    Kostolanský F; Mucha V; Slováková R; Varecková E
    Acta Virol; 2002; 46(4):229-36. PubMed ID: 12693859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
    Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
    Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice.
    Cox RJ; Hovden AO; Brokstad KA; Szyszko E; Madhun AS; Haaheim LR
    Vaccine; 2006 Nov; 24(44-46):6585-7. PubMed ID: 16839650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection against influenza infection by cytokine-enhanced aerosol genetic immunization.
    Orson FM; Kinsey BM; Densmore CL; Nguyen T; Wu Y; Mbawuike IN; Wyde PR
    J Gene Med; 2006 Apr; 8(4):488-97. PubMed ID: 16389596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of long-life radioisotopes Sr90 and Cs137 on the formation of antibodies to influenza A virus].
    Shubik VM
    Vopr Virusol; 1968; 13(5):592-5. PubMed ID: 5708929
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the incorporation of a thymus extract labeled with P32 during anti-influenza immunization in mice].
    Babes VT; Burducea O; Mocanu N; Petrescu A; Weiner
    Stud Cercet Inframicrobiol; 1970; 21(4):291-6. PubMed ID: 5486118
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of bacterial peptidoglycans on the immune response of hamsters to influenza virus vaccines.
    Crawford CR; Jennings R; Bradford N; Potter CW
    Clin Exp Immunol; 1982 Jun; 48(3):739-46. PubMed ID: 6811173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant.
    Hasegawa H; Ichinohe T; Strong P; Watanabe I; Ito S; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T
    J Med Virol; 2005 Jan; 75(1):130-6. PubMed ID: 15543590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza viruses and lympho-macrophagic cells. I. In vitro interaction between influenza A2-59 virus (H2N2) and peritoneal macrophagic cells from normal or immunized mice and rats.
    Alexandrescu M; Handrache L; Moroşanu V; Vancea G; Ionescu L; Colev A
    Rev Roum Virol (1972); 1974; 25(1):3-14. PubMed ID: 4413880
    [No Abstract]   [Full Text] [Related]  

  • 33. Delay of fatal pneumonia in x-irradiated mice inoculated with mouse-adapted influenza virus, PR8 strain.
    Berlin BS; Cochran KW
    Radiat Res; 1967 Jun; 31(2):343-51. PubMed ID: 6025867
    [No Abstract]   [Full Text] [Related]  

  • 34. [Long-term effect of oral immunization against influenza with a gamma ray-inactivated vaccine in mice].
    Noack K; Tischner H; Bräuniger S; Nordheim W; Pohl WD
    Z Erkr Atmungsorgane; 1986; 166(3):286-9. PubMed ID: 3751154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of endogenous hypocorticism on the replication of influenza virus in the mouse lungs and the production of specific antibodies.
    Semenkov VF; Levina LV; Lavrov VF; Ageeva ON
    Acta Virol; 1990 Feb; 34(1):37-43. PubMed ID: 1975723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model.
    Lipatov AS; Webby RJ; Govorkova EA; Krauss S; Webster RG
    J Infect Dis; 2005 Apr; 191(8):1216-20. PubMed ID: 15776365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
    Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Further immunity tests on a mouse-lethal influenza virus strain Hong Kong with reference to its subtype. II].
    Herzberg K
    Zentralbl Bakteriol Orig; 1971; 216(4):421-7. PubMed ID: 5088345
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of the ability of canarypox-vectored equine influenza virus vaccines to induce humoral immune responses against canine influenza viruses in dogs.
    Karaca K; Dubovi EJ; Siger L; Robles A; Audonnet JC; Jiansheng Y; Nordgren R; Minke JM
    Am J Vet Res; 2007 Feb; 68(2):208-12. PubMed ID: 17269888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies of the effects of BCG and Corynebacterium parvum vaccines in experimental infection of mice with influenza virus. Foot pad test, splenic indicator and histologic changes in the thymus gland, spleen and lymph nodes].
    Ciebiada I; Błoch P; Kulig A; Denys A
    Med Dosw Mikrobiol; 1989; 41(2):92-9. PubMed ID: 2586194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.